REGENXBIO Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $377.8M | $338.4M |
| FY2021 | — | $764.3M | $345.2M |
| FY2022 | — | $516.2M | $97.0M |
| FY2023 | — | $311.7M | $34.5M |
| FY2024 | — | $259.7M | $57.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $377.8M | $338.4M |
| FY2021 | — | $764.3M | $345.2M |
| FY2022 | — | $516.2M | $97.0M |
| FY2023 | — | $311.7M | $34.5M |
| FY2024 | — | $259.7M | $57.5M |